Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.

Rodón L, Svensson RU, Wiater E, Chun MGH, Tsai WW, Eichner LJ, Shaw RJ, Montminy M.

Sci Adv. 2019 Jul 24;5(7):eaaw6455. doi: 10.1126/sciadv.aaw6455. eCollection 2019 Jul.

2.

CREB Promotes Beta Cell Gene Expression by Targeting Its Coactivators to Tissue-Specific Enhancers.

Van de Velde S, Wiater E, Tran M, Hwang Y, Cole PA, Montminy M.

Mol Cell Biol. 2019 Aug 12;39(17). pii: e00200-19. doi: 10.1128/MCB.00200-19. Print 2019 Sep 1.

PMID:
31182641
3.

cAMP-inducible coactivator CRTC3 attenuates brown adipose tissue thermogenesis.

Yoon YS, Tsai WW, Van de Velde S, Chen Z, Lee KF, Morgan DA, Rahmouni K, Matsumura S, Wiater E, Song Y, Montminy M.

Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):E5289-E5297. doi: 10.1073/pnas.1805257115. Epub 2018 May 21.

4.

β2-Agonists Enhance Asthma-Relevant Inflammatory Mediators in Human Airway Epithelial Cells.

Ritchie AI, Singanayagam A, Wiater E, Edwards MR, Montminy M, Johnston SL.

Am J Respir Cell Mol Biol. 2018 Jan;58(1):128-132. doi: 10.1165/rcmb.2017-0315LE. No abstract available.

5.

CREB coactivators CRTC2 and CRTC3 modulate bone marrow hematopoiesis.

Kim JH, Hedrick S, Tsai WW, Wiater E, Le Lay J, Kaestner KH, Leblanc M, Loar A, Montminy M.

Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):11739-11744. doi: 10.1073/pnas.1712616114. Epub 2017 Oct 16.

6.

Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome Registry.

Mądry K, Machowicz R, Waszczuk-Gajda A, Drozd-Sokołowska J, Hołowiecka BS, Wiater E, Mital A, Obara A, Szmigielska-Kapłon A, Kołkowska-Leśniak A, Sikorska A, Subocz E, Mendrek W, Szczepańska M, Biedroń M, Jachalska A, Wasilewska E, Wojciechowska M, Guzicka-Kazimierczak R, Kopacz A, Katinas K, Kruger W, Dawidowska A, Salamańczuk Z, Zawirska D, Świderska A, Jędrzejczak WW, Dwilewicz-Trojaczek J.

Acta Haematol. 2015;134(2):125-34. doi: 10.1159/000375149. Epub 2015 Apr 24.

PMID:
25925777
7.

High-dose melphalan and autologous hematopoietic stem cell transplantation in primary amyloidosis: single-center results.

Charlinski G, Ziarkiewicz M, Boguradzki P, Wiater E, Torosian T, Dwilewicz-Trojaczek J, Wiktor-Jedrzejczak W.

Transplant Proc. 2014 Oct;46(8):2877-81. doi: 10.1016/j.transproceed.2014.09.053.

PMID:
25380940
8.

Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.

Blonski JZ, Robak T, Chojnowski K, Gora-Tybor J, Warzocha K, Ceglarek B, Seferynska I, Calbecka M, Kostyra A, Stella-Holowiecka B, Kloczko J, Dmoszynska A, Kowal M, Lewandowski K, Dwilewicz-Trojaczek J, Wiater E, Kuliczkowski K, Potoczek S, Hellmann A, Mital A, Skotnicki A, Nowak W, Sulek K, Zawilska K, Trelinski J.

Eur J Haematol. 2013 Jul;91(1):1-9. doi: 10.1111/ejh.12112. Epub 2013 Apr 19.

PMID:
23521128
9.

[Immunomodulatory drugs in the treatment of primary systemic light chain amyloidosis].

Charliński G, Wiater E, Jedrzejczak WW.

Pol Merkur Lekarski. 2012 Apr;32(190):217-20. Polish.

PMID:
22708276
10.

Roles of activin family in pancreatic development and homeostasis.

Wiater E, Vale W.

Mol Cell Endocrinol. 2012 Aug 15;359(1-2):23-9. doi: 10.1016/j.mce.2012.02.015. Epub 2012 Mar 3. Review.

PMID:
22406274
11.

Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Bilezikjian LM, Justice NJ, Blackler AN, Wiater E, Vale WW.

Mol Cell Endocrinol. 2012 Aug 15;359(1-2):43-52. doi: 10.1016/j.mce.2012.01.025. Epub 2012 Feb 4. Review.

12.

Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan.

Looyenga BD, Wiater E, Vale W, Hammer GD.

Mol Endocrinol. 2010 Mar;24(3):608-20. doi: 10.1210/me.2008-0374. Epub 2010 Feb 16.

13.

Endogenous betaglycan is essential for high-potency inhibin antagonism in gonadotropes.

Wiater E, Lewis KA, Donaldson C, Vaughan J, Bilezikjian L, Vale W.

Mol Endocrinol. 2009 Jul;23(7):1033-42. doi: 10.1210/me.2009-0021. Epub 2009 Apr 16.

14.

Presence, actions, and regulation of myostatin in rat uterus and myometrial cells.

Ciarmela P, Wiater E, Smith SM, Vale W.

Endocrinology. 2009 Feb;150(2):906-14. doi: 10.1210/en.2008-0880. Epub 2008 Oct 9.

15.

[Study of subpopulations of lymphocytes in the bone marrow of patients with myelodysplastic syndromes].

Wiater E, Dwilewicz-Trojaczek J.

Pol Arch Med Wewn. 2006 Mar;115(3):210-8. Polish.

PMID:
18468426
16.

Activin-A in myometrium: characterization of the actions on myometrial cells.

Ciarmela P, Wiater E, Vale W.

Endocrinology. 2008 May;149(5):2506-16. doi: 10.1210/en.2007-0692. Epub 2008 Jan 31.

17.

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.

Robak T, Jamroziak K, Gora-Tybor J, Blonski JZ, Kasznicki M, Dwilewicz-Trojaczek J, Wiater E, Zdunczyk A, Dybowicz J, Dmoszynska A, Wojtaszko M, Zdziarska B, Calbecka M, Kostyra A, Hellmann A, Lewandowski K, Stella-Holowiecka B, Sulek K, Gawronski K, Skotnicki AB, Nowak W, Zawilska K, Molendowicz-Portala L, Kloczko J, Sokolowski J, Warzocha K, Seferynska I, Ceglarek B, Konopka L.

Blood. 2007 May 1;109(9):3672-5. Epub 2007 Jan 5.

18.

Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions.

Wiater E, Harrison CA, Lewis KA, Gray PC, Vale WW.

J Biol Chem. 2006 Jun 23;281(25):17011-22. Epub 2006 Apr 18.

19.

Activins and inhibins and their signaling.

Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S.

Ann N Y Acad Sci. 2004 Dec;1038:142-7.

PMID:
15838109
20.

Modulation of activin and BMP signaling.

Harrison CA, Wiater E, Gray PC, Greenwald J, Choe S, Vale W.

Mol Cell Endocrinol. 2004 Oct 15;225(1-2):19-24. Review.

PMID:
15451563
21.

Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats.

Takabe K, Wang L, Leal AM, Macconell LA, Wiater E, Tomiya T, Ohno A, Verma IM, Vale W.

Hepatology. 2003 Nov;38(5):1107-15.

PMID:
14578849
22.

Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein.

Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Baban K, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S.

J Bone Joint Surg Am. 2003;85-A Suppl 3:52-8.

PMID:
12925610
23.

The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly.

Greenwald J, Groppe J, Gray P, Wiater E, Kwiatkowski W, Vale W, Choe S.

Mol Cell. 2003 Mar;11(3):605-17.

24.

Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding.

Fischer WH, Park M, Donaldson C, Wiater E, Vaughan J, Bilezikjian LM, Vale W.

J Endocrinol. 2003 Jan;176(1):61-8.

PMID:
12525250
25.

Inhibin is an antagonist of bone morphogenetic protein signaling.

Wiater E, Vale W.

J Biol Chem. 2003 Mar 7;278(10):7934-41. Epub 2002 Dec 18.

26.

Structural basis of BMP signalling inhibition by the cystine knot protein Noggin.

Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S.

Nature. 2002 Dec 12;420(6916):636-42.

PMID:
12478285
27.

[Analysis of pregnancy course and delivery in girls below 19 years of age].

Gajewska M, Karwan-Płońska A, Skrzos-Buciak M, Wiater E.

Ginekol Pol. 2000 Aug;71(8):658-62. Polish.

PMID:
11082897
28.

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.

Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W.

Nature. 2000 Mar 23;404(6776):411-4.

PMID:
10746731
29.

Inactivation of activin-dependent transcription by kinase-deficient activin receptors.

Tsuchida K, Vaughan JM, Wiater E, Gaddy-Kurten D, Vale WW.

Endocrinology. 1995 Dec;136(12):5493-503.

PMID:
7588300
30.

Letters to editor.

Wiater EJ.

Calif Med. 1967 Jun;106(6):499-500. No abstract available.

Supplemental Content

Loading ...
Support Center